Literature DB >> 22236843

Mortality trends for tuberculosis and sarcoidosis in English populations, 1979-2008.

M E Duncan1, M J Goldacre.   

Abstract

SETTING: Analysis of data sets that included both underlying and all contributing causes of death (together termed 'mentions'): the Oxford Record Linkage Study, 1979-2008, and England national data, 1995-2008.
OBJECTIVE: To determine mortality trends for the granulomatous lung conditions tuberculosis (TB) and sarcoidosis in the Oxford region (1979-2008) and England (1995-2008).
RESULTS: Mortality for mentions of TB in the Oxford region declined from 39.7 deaths per million population in 1979 to 9.0 in 2008. The corresponding rates for underlying cause were 17.1, falling to 4.5. In England, mortality rates from TB fell from 18.5/million in 1995 to 12.2 in 2008 (mentions), and from 9.3 in 1995 to 6.5 in 2008 (underlying cause). Numbers of deaths from sarcoidosis in Oxford were very small, and showed no significant trend. For the much larger England population, mortality rates based on mentions were 3.6/million in 1995 and 4.2 in 2008; the corresponding rates for sarcoidosis as underlying cause were 2.1 and 2.3.
CONCLUSION: TB mortality is still declining in England, despite a recent resurgence in the prevalence of the disease. Mortality from sarcoidosis has been largely stable. The conventional statistic of underlying cause of death missed almost half of all certified TB and sarcoidosis deaths.

Entities:  

Mesh:

Year:  2012        PMID: 22236843     DOI: 10.5588/ijtld.11.0077

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

Review 1.  Morbidity and mortality in sarcoidosis.

Authors:  Alicia K Gerke
Journal:  Curr Opin Pulm Med       Date:  2014-09       Impact factor: 3.155

2.  Sarcoidosis and increased risk of comorbidities and mortality in sweden.

Authors:  Johanna Larsson; Pål Graff; Ing-Liss Bryngelsson; Per Vihlborg
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-06-30       Impact factor: 0.670

3.  In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012.

Authors:  Susanne Pohle; Florent Baty; Martin Brutsche
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

4.  Sarcoidosis mortality in Sweden: a population-based cohort study.

Authors:  Marios Rossides; Susanna Kullberg; Johan Askling; Anders Eklund; Johan Grunewald; Elizabeth V Arkema
Journal:  Eur Respir J       Date:  2018-02-21       Impact factor: 16.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.